Getty Pictures, NBC Information section spotlight articles and TV interviews about Corporate’s CBD hemp oil; characteristic executives talking on burgeoning trade
June 19, 2017 —
SAN DIEGO, June 19, 2017 /PRNewswire/ — Clinical Marijuana, Inc. (OTC: MJNA), the primary publicly traded hashish corporate in the USA, these days introduced that it garnered in depth media protection from the 4th Annual Hashish International Congress and Trade Expo in New York, which came about on June 14-16.
Clinical Marijuana, Inc.’s CEO Dr. Stuart Titus spoke to a number of tv and radio stations in regards to the healing houses of hashish, fresh breakthroughs in scientific hashish analysis, and the Corporate’s groundbreaking Actual Clinical Hemp Oil (RSHO) and zero-THC Actual Clinical Hemp Oil-X (RSHO-X).
“We’re thankful to the clicking and to the Global Hashish Affiliation for serving as an efficient platform to boost consciousness at the plethora of advantages of cannabidiol (CBD),” stated Clinical Marijuana, Inc. CEO Dr. Stuart Titus. “The CWCBE in New York was once an enormous luck. During the media’s protection of the development, audience and readers international acquire a a lot better figuring out of the ability of hemp oil and hashish merchandise, in addition to the companies which might be shaping and supporting this abruptly rising trade.”
Protection from the Expo integrated:
About Clinical Marijuana, Inc.
We’re an organization of firsts ®. Our challenge is to be the premier hashish and hemp trade innovators, leveraging our workforce of pros to supply, evaluation and buy value-added corporations and merchandise, whilst letting them stay their integrity and entrepreneurial spirit. We try to create consciousness inside of our trade, broaden environmentally-friendly, economically sustainable companies, whilst expanding shareholder cost. For main points on Clinical Marijuana, Inc.’s portfolio and funding corporations, discuss with www.medicalmarijuanainc.com.
To peer Clinical Marijuana, Inc.’s video observation, click on right here. Shareholders also are inspired to discuss with the Clinical Marijuana, Inc. Store for discounted merchandise.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES.
This press unencumber would possibly include sure forward-looking statements and knowledge, as outlined throughout the that means of Segment 27A of the Securities Act of 1933 and Segment 21E of the Securities Alternate Act of 1934, and is topic to the Secure Harbor created via the ones sections. This subject material comprises statements about anticipated long run occasions and/or monetary effects which might be forward-looking in nature and topic to dangers and uncertainties. Such forward-looking statements via definition contain dangers, uncertainties. The statements on this press unencumber have now not been evaluated via the FDA and aren’t supposed to diagnose, deal with or remedy any illness. The Corporate does now not promote or distribute any merchandise which might be in violation of the USA Managed Components Act. The Corporate does promote and distribute hemp-based merchandise.
Public Family members Touch:
Leader Government Officer
P: 888-829- 0070
To view the unique model on PR Newswire, discuss with:http://www.prnewswire.com/news-releases/medical-marijuana-inc-garners-national-news-coverage-at-4th-annual-cannabis-world-congress-and-business-expo-in-new-york-300475672.html
SOURCE Clinical Marijuana, Inc.
Copyright 2014 PR Newswire. All Rights Reserved